Cochrane COVID-19 Study Register
Study record
NCT05043311First Published: 2021 Sep 14Updated Date: 2021 Sep 14

A Randomized, Double-blinded, Placebo-controlled Phase I/II/III Clinical Trial to Evaluate the Safety, Tolerability, Immunogenicity, and Protective Efficacy of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated Vaccine Against COVID-19 Healthy Population Aged ≥18 Years Previously Vaccinated With Adenovirus Vectored or mRNA Vaccine Against COVID-19

  1. Study Type
  2. Interventional
  1. Study Aim
  2. Prevention
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Randomised
Reference record

The Safety and Efficacy of SCTV01C in Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine.Healthy Population Aged ≥18 Years Previously Vaccinated With Adenovirus Vectored or mRNA COVID-19 Vaccine

Sinocelltech Ltd.
First Published (first received 2021 September 14)ClinicalTrials.gov (https://clinicaltrials.gov/show/NCT05043311)
Trial registry record
No Results
The objective of this study is to evaluate the safety, tolerability, immunogenicity, and protective efficacy of SCTV01C in healthy population aged ≥18 years previously vaccinated with adenovirus vectored or mRNA COVID-19 vaccine